Genelux Return on Equity (ROE) Growth & History (GNLX)
Genelux's return on equity was −170.00% for fiscal 2025.
View full Genelux company overviewGenelux annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −170.00% | −39.41 pp |
| 2024 | 2024-12-31 | −130.58% | — |
Genelux quarterly return on equity
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −48.53% | −20.78 pp |
| Q1 2026 | 2026-03-31 | −51.81% | −25.11 pp |
| Q4 2025 | 2025-12-31 | −61.37% | −31.13 pp |
| Q3 2025 | 2025-09-30 | −37.42% | −19.14 pp |
| Q2 2025 | 2025-06-30 | −27.75% | −2.82 pp |
| Q1 2025 | 2025-03-31 | −26.70% | +18.73 pp |
| Q4 2024 | 2024-12-31 | −30.24% | +0.87 pp |
| Q3 2024 | 2024-09-30 | −18.28% | +4.82 pp |
| Q2 2024 | 2024-06-30 | −24.93% | +21.74 pp |
| Q1 2024 | 2024-03-31 | −45.43% | — |
| Q4 2023 | 2023-12-31 | −31.11% | — |
| Q3 2023 | 2023-09-30 | −23.10% | — |
| Q2 2023 | 2023-06-30 | −46.67% | — |
Genelux return on equity trends
Between the periods ended 2024-12-31 and 2025-12-31, Genelux's return on equity decreased from −130.58% to −170.00%, a change of −39.41 percentage points. The latest reported quarter, Q2 2026, shows −48.53%.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Genelux source filings ↗